Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumococcal Infections | 28 | 2022 | 502 | 5.550 |
Why?
|
Carrier State | 29 | 2021 | 525 | 5.520 |
Why?
|
Streptococcus pneumoniae | 29 | 2021 | 731 | 5.430 |
Why?
|
Israel | 59 | 2024 | 722 | 4.870 |
Why?
|
Pneumococcal Vaccines | 21 | 2022 | 397 | 4.420 |
Why?
|
Staphylococcus aureus | 19 | 2020 | 1459 | 3.480 |
Why?
|
Staphylococcal Infections | 21 | 2020 | 1409 | 3.120 |
Why?
|
Antibodies, Viral | 24 | 2024 | 3155 | 2.690 |
Why?
|
Antibodies, Neutralizing | 19 | 2024 | 1942 | 2.570 |
Why?
|
Nasopharynx | 15 | 2019 | 398 | 2.200 |
Why?
|
Health Personnel | 15 | 2024 | 3331 | 2.030 |
Why?
|
Vaccines, Conjugate | 10 | 2022 | 328 | 1.570 |
Why?
|
Antibiosis | 5 | 2018 | 45 | 1.550 |
Why?
|
Immunoglobulin G | 14 | 2024 | 4549 | 1.390 |
Why?
|
Community-Acquired Infections | 8 | 2019 | 468 | 1.320 |
Why?
|
Immunization, Secondary | 6 | 2023 | 368 | 1.300 |
Why?
|
Vaccination | 22 | 2024 | 3375 | 1.260 |
Why?
|
Vaccines | 6 | 2023 | 836 | 1.020 |
Why?
|
Influenza Vaccines | 2 | 2023 | 763 | 0.980 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 7 | 2018 | 699 | 0.970 |
Why?
|
Immunity, Humoral | 3 | 2024 | 604 | 0.890 |
Why?
|
Fimbriae Proteins | 2 | 2016 | 132 | 0.850 |
Why?
|
Cross Infection | 10 | 2021 | 1438 | 0.850 |
Why?
|
Laundry Service, Hospital | 1 | 2021 | 2 | 0.800 |
Why?
|
Disease Outbreaks | 7 | 2024 | 1762 | 0.790 |
Why?
|
Enterobacteriaceae Infections | 1 | 2023 | 193 | 0.780 |
Why?
|
Pneumonia, Pneumococcal | 2 | 2022 | 131 | 0.770 |
Why?
|
Immunity, Herd | 3 | 2021 | 46 | 0.760 |
Why?
|
Meningitis, Pneumococcal | 2 | 2018 | 43 | 0.750 |
Why?
|
Methicillin Resistance | 6 | 2018 | 198 | 0.730 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 587 | 0.730 |
Why?
|
Orthomyxoviridae | 1 | 2021 | 147 | 0.710 |
Why?
|
Influenza, Human | 2 | 2021 | 1517 | 0.700 |
Why?
|
Serratia Infections | 1 | 2018 | 8 | 0.640 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2019 | 1351 | 0.640 |
Why?
|
Serratia marcescens | 1 | 2018 | 48 | 0.620 |
Why?
|
Masks | 1 | 2020 | 208 | 0.610 |
Why?
|
Molecular Typing | 3 | 2016 | 116 | 0.610 |
Why?
|
Immunization Programs | 3 | 2016 | 268 | 0.580 |
Why?
|
Equipment Contamination | 1 | 2018 | 181 | 0.570 |
Why?
|
Hydrogen Peroxide | 4 | 2016 | 728 | 0.550 |
Why?
|
Humans | 119 | 2024 | 760437 | 0.530 |
Why?
|
Infant | 34 | 2022 | 36183 | 0.520 |
Why?
|
Schools | 2 | 2022 | 1488 | 0.500 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 557 | 0.490 |
Why?
|
Infection Control | 6 | 2021 | 985 | 0.460 |
Why?
|
Adult | 48 | 2024 | 220781 | 0.460 |
Why?
|
Serotyping | 6 | 2022 | 326 | 0.430 |
Why?
|
Female | 66 | 2024 | 391875 | 0.410 |
Why?
|
Male | 60 | 2024 | 360035 | 0.410 |
Why?
|
Neutralization Tests | 2 | 2024 | 728 | 0.410 |
Why?
|
Anti-Bacterial Agents | 16 | 2022 | 7424 | 0.400 |
Why?
|
Child, Preschool | 27 | 2022 | 42209 | 0.400 |
Why?
|
Vaccines, Synthetic | 3 | 2024 | 619 | 0.390 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 5 | 2018 | 143 | 0.390 |
Why?
|
Interleukin-17 | 1 | 2018 | 907 | 0.390 |
Why?
|
Middle Aged | 41 | 2024 | 220382 | 0.380 |
Why?
|
Population Surveillance | 4 | 2018 | 2603 | 0.370 |
Why?
|
Pyruvate Oxidase | 2 | 2007 | 7 | 0.370 |
Why?
|
Microbial Viability | 2 | 2009 | 238 | 0.340 |
Why?
|
Contact Tracing | 2 | 2022 | 270 | 0.330 |
Why?
|
Nose | 3 | 2020 | 521 | 0.330 |
Why?
|
Rectum | 4 | 2019 | 892 | 0.320 |
Why?
|
Prospective Studies | 20 | 2024 | 54339 | 0.320 |
Why?
|
Fimbriae, Bacterial | 1 | 2009 | 138 | 0.310 |
Why?
|
Prevalence | 9 | 2021 | 15698 | 0.310 |
Why?
|
Meningococcal Vaccines | 1 | 2008 | 94 | 0.300 |
Why?
|
Pandemics | 7 | 2022 | 8623 | 0.300 |
Why?
|
Infant, Newborn | 19 | 2024 | 26280 | 0.290 |
Why?
|
Aged | 28 | 2024 | 168840 | 0.270 |
Why?
|
Klebsiella pneumoniae | 2 | 2023 | 256 | 0.270 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 26063 | 0.260 |
Why?
|
Haemophilus influenzae | 2 | 2016 | 180 | 0.260 |
Why?
|
Child | 21 | 2022 | 80086 | 0.250 |
Why?
|
Drug Resistance, Bacterial | 6 | 2019 | 1058 | 0.250 |
Why?
|
Microbial Sensitivity Tests | 8 | 2018 | 1952 | 0.250 |
Why?
|
Nasal Mucosa | 2 | 2019 | 415 | 0.250 |
Why?
|
Triage | 3 | 2021 | 986 | 0.240 |
Why?
|
Umbilicus | 2 | 2017 | 36 | 0.240 |
Why?
|
Intensive Care Units | 1 | 2018 | 3742 | 0.240 |
Why?
|
Tuberculosis, Spinal | 1 | 2004 | 16 | 0.240 |
Why?
|
Retropharyngeal Abscess | 1 | 2004 | 21 | 0.240 |
Why?
|
DNA, Bacterial | 4 | 2018 | 1481 | 0.240 |
Why?
|
Young Adult | 19 | 2021 | 59068 | 0.240 |
Why?
|
Genotype | 4 | 2018 | 12976 | 0.230 |
Why?
|
Ear | 2 | 2017 | 172 | 0.230 |
Why?
|
Parents | 3 | 2020 | 3563 | 0.230 |
Why?
|
Meningitis, Bacterial | 2 | 2017 | 221 | 0.220 |
Why?
|
Specimen Handling | 1 | 2008 | 703 | 0.220 |
Why?
|
Primaquine | 2 | 2000 | 28 | 0.220 |
Why?
|
Roxithromycin | 1 | 2022 | 3 | 0.220 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39078 | 0.220 |
Why?
|
Adolescent | 22 | 2022 | 88196 | 0.210 |
Why?
|
Penicillin Resistance | 1 | 2003 | 82 | 0.210 |
Why?
|
Epidural Abscess | 1 | 2004 | 94 | 0.210 |
Why?
|
RNA, Viral | 2 | 2021 | 2846 | 0.210 |
Why?
|
Ceftriaxone | 2 | 2022 | 175 | 0.210 |
Why?
|
Clostridium Infections | 2 | 2020 | 558 | 0.200 |
Why?
|
Enterobacteriaceae | 1 | 2023 | 174 | 0.200 |
Why?
|
Fomites | 1 | 2021 | 15 | 0.200 |
Why?
|
Bacterial Proteins | 4 | 2023 | 3842 | 0.200 |
Why?
|
Statistics as Topic | 1 | 2008 | 2357 | 0.200 |
Why?
|
Drug Prescriptions | 1 | 2011 | 1669 | 0.190 |
Why?
|
Incidence | 9 | 2022 | 21322 | 0.190 |
Why?
|
beta-Lactamases | 1 | 2023 | 305 | 0.190 |
Why?
|
Cohort Studies | 8 | 2023 | 41366 | 0.190 |
Why?
|
Bacteremia | 3 | 2017 | 979 | 0.190 |
Why?
|
Molecular Epidemiology | 2 | 2015 | 468 | 0.190 |
Why?
|
RNA, Messenger | 5 | 2022 | 12785 | 0.190 |
Why?
|
Boutonneuse Fever | 1 | 2000 | 1 | 0.190 |
Why?
|
Immunoglobulin A | 2 | 2021 | 980 | 0.190 |
Why?
|
Liver Transplantation | 2 | 2023 | 2332 | 0.180 |
Why?
|
Ships | 1 | 2020 | 53 | 0.180 |
Why?
|
Hospitals, Special | 1 | 2021 | 91 | 0.180 |
Why?
|
Vagina | 2 | 2019 | 838 | 0.180 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14565 | 0.180 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2000 | 94 | 0.170 |
Why?
|
Streptococcal Infections | 1 | 2004 | 616 | 0.170 |
Why?
|
Cluster Analysis | 3 | 2012 | 2711 | 0.170 |
Why?
|
Aged, 80 and over | 15 | 2023 | 58859 | 0.170 |
Why?
|
Mass Vaccination | 1 | 2021 | 109 | 0.170 |
Why?
|
Quinolones | 1 | 2022 | 378 | 0.160 |
Why?
|
Haemophilus Infections | 2 | 2016 | 95 | 0.160 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2006 | 842 | 0.160 |
Why?
|
Disease Reservoirs | 1 | 2018 | 121 | 0.150 |
Why?
|
Respiratory Tract Infections | 2 | 2016 | 1010 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 249 | 0.150 |
Why?
|
Cervical Vertebrae | 1 | 2004 | 981 | 0.150 |
Why?
|
Odds Ratio | 3 | 2018 | 9639 | 0.150 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2018 | 587 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 4567 | 0.140 |
Why?
|
Family Characteristics | 1 | 2022 | 1000 | 0.140 |
Why?
|
Bayes Theorem | 2 | 2022 | 2326 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 484 | 0.140 |
Why?
|
Sepsis | 3 | 2017 | 2583 | 0.140 |
Why?
|
Medical Staff, Hospital | 1 | 2021 | 601 | 0.140 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7860 | 0.140 |
Why?
|
Bacterial Toxins | 2 | 2020 | 932 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 596 | 0.140 |
Why?
|
Arabs | 2 | 2015 | 186 | 0.130 |
Why?
|
Middle East | 2 | 2018 | 231 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2021 | 855 | 0.130 |
Why?
|
Antimalarials | 2 | 2000 | 907 | 0.130 |
Why?
|
Communicable Disease Control | 2 | 2020 | 848 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1841 | 0.120 |
Why?
|
Treatment Failure | 1 | 2021 | 2642 | 0.120 |
Why?
|
Age Factors | 6 | 2022 | 18379 | 0.120 |
Why?
|
Penicillins | 2 | 2022 | 406 | 0.120 |
Why?
|
Anaphylaxis | 1 | 2021 | 757 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2806 | 0.110 |
Why?
|
Travel | 1 | 1999 | 795 | 0.110 |
Why?
|
Jews | 1 | 2015 | 364 | 0.110 |
Why?
|
Species Specificity | 1 | 2018 | 2417 | 0.110 |
Why?
|
Interleukins | 1 | 2018 | 782 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2017 | 2151 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2018 | 1176 | 0.100 |
Why?
|
Immunity | 3 | 2022 | 997 | 0.100 |
Why?
|
International Cooperation | 1 | 2018 | 1428 | 0.100 |
Why?
|
History, 21st Century | 1 | 2018 | 1567 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2021 | 22097 | 0.100 |
Why?
|
Linear Models | 1 | 2021 | 5865 | 0.090 |
Why?
|
Escherichia coli | 1 | 2023 | 4234 | 0.090 |
Why?
|
Methicillin | 1 | 2011 | 62 | 0.090 |
Why?
|
Th17 Cells | 1 | 2018 | 792 | 0.090 |
Why?
|
Mothers | 2 | 2020 | 2191 | 0.090 |
Why?
|
Pregnancy | 5 | 2024 | 29831 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2011 | 504 | 0.090 |
Why?
|
Malaria | 1 | 1999 | 1225 | 0.090 |
Why?
|
Catalase | 2 | 2009 | 217 | 0.080 |
Why?
|
DNA Fingerprinting | 1 | 2009 | 114 | 0.080 |
Why?
|
Otitis Media | 2 | 2016 | 285 | 0.080 |
Why?
|
Operon | 1 | 2010 | 374 | 0.080 |
Why?
|
Carbapenems | 1 | 2010 | 124 | 0.080 |
Why?
|
Culture | 1 | 2013 | 623 | 0.080 |
Why?
|
Bacterial Typing Techniques | 1 | 2009 | 264 | 0.080 |
Why?
|
Klebsiella Infections | 1 | 2010 | 148 | 0.080 |
Why?
|
Neoplasms | 3 | 2022 | 22083 | 0.080 |
Why?
|
Drug Resistance, Microbial | 1 | 2011 | 857 | 0.080 |
Why?
|
Sex Factors | 1 | 2021 | 10538 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3880 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3190 | 0.070 |
Why?
|
Retrospective Studies | 11 | 2024 | 80430 | 0.070 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 330 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2023 | 12054 | 0.070 |
Why?
|
Risk Factors | 10 | 2019 | 74055 | 0.070 |
Why?
|
Virus Activation | 1 | 2009 | 322 | 0.070 |
Why?
|
Child Day Care Centers | 2 | 2008 | 122 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10188 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12969 | 0.060 |
Why?
|
Bacteriophages | 1 | 2009 | 378 | 0.060 |
Why?
|
Fungemia | 1 | 2005 | 57 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7817 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2007 | 696 | 0.060 |
Why?
|
Azithromycin | 2 | 2022 | 199 | 0.060 |
Why?
|
Drug Utilization | 1 | 2011 | 1188 | 0.060 |
Why?
|
Candida | 1 | 2005 | 173 | 0.060 |
Why?
|
Health Education | 1 | 2010 | 1052 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3800 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12932 | 0.060 |
Why?
|
Health Policy | 1 | 2016 | 2680 | 0.060 |
Why?
|
Time Factors | 2 | 2021 | 39947 | 0.050 |
Why?
|
Secretory Component | 1 | 2022 | 16 | 0.050 |
Why?
|
Residence Characteristics | 2 | 2021 | 2087 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Hospitalization | 3 | 2019 | 10698 | 0.050 |
Why?
|
Candida albicans | 1 | 2005 | 372 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 225 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2007 | 2676 | 0.050 |
Why?
|
Macrolides | 1 | 2022 | 205 | 0.050 |
Why?
|
Carnobacteriaceae | 1 | 2020 | 10 | 0.050 |
Why?
|
Age Distribution | 2 | 2005 | 2878 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2462 | 0.040 |
Why?
|
Streptococcus | 1 | 2020 | 198 | 0.040 |
Why?
|
Bacterial Shedding | 1 | 2020 | 10 | 0.040 |
Why?
|
Mefloquine | 1 | 1999 | 55 | 0.040 |
Why?
|
Environmental Microbiology | 1 | 2020 | 46 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 397 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6570 | 0.040 |
Why?
|
Antibodies, Bacterial | 2 | 2008 | 1469 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 397 | 0.040 |
Why?
|
Risk Assessment | 3 | 2021 | 23953 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2019 | 131 | 0.040 |
Why?
|
Public Health | 1 | 2011 | 2665 | 0.040 |
Why?
|
Malaria, Vivax | 1 | 2000 | 166 | 0.040 |
Why?
|
Plasmodium vivax | 1 | 1999 | 202 | 0.040 |
Why?
|
Doxycycline | 1 | 1999 | 344 | 0.040 |
Why?
|
Sex Distribution | 1 | 2003 | 2281 | 0.040 |
Why?
|
Penicillin-Binding Proteins | 1 | 2018 | 148 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5332 | 0.040 |
Why?
|
Probability | 1 | 2003 | 2476 | 0.040 |
Why?
|
Massachusetts | 1 | 2010 | 8826 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2003 | 2927 | 0.040 |
Why?
|
Metagenomics | 1 | 2020 | 466 | 0.040 |
Why?
|
Leukocidins | 1 | 2016 | 18 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1037 | 0.030 |
Why?
|
Exotoxins | 1 | 2016 | 121 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 8163 | 0.030 |
Why?
|
Pediatrics | 1 | 2011 | 3593 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 851 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3996 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2004 | 1374 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1530 | 0.030 |
Why?
|
Oropharynx | 1 | 2016 | 138 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 1999 | 426 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 786 | 0.030 |
Why?
|
Immunization | 1 | 1999 | 1226 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3419 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1750 | 0.030 |
Why?
|
United States | 1 | 2021 | 72202 | 0.030 |
Why?
|
Feces | 1 | 2020 | 1494 | 0.030 |
Why?
|
Placenta | 1 | 2021 | 1704 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2021 | 1157 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6086 | 0.020 |
Why?
|
Apoptosis | 1 | 2007 | 9468 | 0.020 |
Why?
|
Rats | 1 | 2007 | 23712 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 17328 | 0.020 |
Why?
|
Plasmodium falciparum | 1 | 1999 | 1741 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14661 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 414 | 0.020 |
Why?
|
Lysogeny | 1 | 2009 | 67 | 0.020 |
Why?
|
Genes, Bacterial | 1 | 2012 | 1079 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2545 | 0.020 |
Why?
|
Mitomycin | 1 | 2009 | 262 | 0.020 |
Why?
|
Bacterial Capsules | 1 | 2008 | 244 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2016 | 64591 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3873 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2010 | 1155 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1340 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2009 | 987 | 0.010 |
Why?
|
Cephalosporins | 1 | 2005 | 204 | 0.010 |
Why?
|
Amoxicillin | 1 | 2005 | 180 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8466 | 0.010 |
Why?
|
Telemedicine | 1 | 2021 | 3027 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5424 | 0.010 |
Why?
|
Candidiasis | 1 | 2005 | 364 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 30025 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5806 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2493 | 0.010 |
Why?
|
Animals | 2 | 2007 | 168253 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13616 | 0.010 |
Why?
|
Infant, Premature | 1 | 2006 | 2104 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2010 | 5283 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7230 | 0.010 |
Why?
|
Drug Resistance | 1 | 2000 | 1597 | 0.010 |
Why?
|
Primary Health Care | 1 | 2010 | 4674 | 0.010 |
Why?
|
Body Weight | 1 | 2000 | 4614 | 0.010 |
Why?
|
Concepts
(288)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_